Epitome Therapeutics
Announced 07 Jul 2026$2.3M ยท Pre-Seed ยท Hospitals and Health Care ยท Austria
Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression.
โFunding Round: Epitome Therapeutics Launches with โฌ4M to Advance Its Epigenome Editing Platform Epitome Therapeutics, a biotechnology company advancing precision epigenome editing, has launched with โฌ4 million in total funding, comprising an oversubscribed โฌ2 million pre-seed round and โฌ2 million in non-dilutive grants.โ
1 more source tracked. Read the full press release and reporter coverage.
Sign up to read โInvestors: XISTA Science Ventures, Caesar Ventures, Navec Venture Holding.